Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2296 AL 2310

Frailty and cognitive impairment in Parkinson's disease: a systematic review

Sousa-Fraguas MC, Rodríguez-Fuentes G, Conejo NM.

Neurol Sci. 2022 Dec;43(12):6693-6706. doi: 10.1007/s10072-022-06347-7. Epub 2022 Sep 2.

The multiple functions of PrP(C) in physiological, cancer, and neurodegenerative contexts

Grimaldi I, Leser FS, Janeiro JM, da Rosa BG, Campanelli AC, Romão L, Lima FRS.

J Mol Med (Berl). 2022 Oct;100(10):1405-1425. doi: 10.1007/s00109-022-02245-9. Epub 2022 Sep 3.

Which type of mind-body exercise is most effective in improving functional performance and quality of life in patients with Parkinson's disease? A systematic review with network meta-analysis

Mustafaoglu R, Ahmed I, Pang MYC.

Acta Neurol Belg. 2022 Dec;122(6):1433-1446. doi: 10.1007/s13760-022-02070-4. Epub 2022 Sep 2.

Importance of Bmal1 in Alzheimer's disease and associated aging-related diseases: Mechanisms and interventions

Fan R, Peng X, Xie L, Dong K, Ma D, Xu W, Shi X, Zhang S, Chen J, Yu X, Yang Y.

Aging Cell. 2022 Oct;21(10):e13704. doi: 10.1111/acel.13704. Epub 2022 Sep 3.

Uric Acid in Parkinson's Disease: What Is the Connection?

Seifar F, Dinasarapu AR, Jinnah HA.

Mov Disord. 2022 Nov;37(11):2173-2183. doi: 10.1002/mds.29209. Epub 2022 Sep 3.

Effects of square-stepping exercise on executive function in individuals with Parkinson's disease: A randomized controlled pilot study

Liu HH, Wang RY, Cheng SJ, Liao KK, Zhou JH, Yang YR.

Geriatr Nurs. 2022 Sep-Oct;47:273-279. doi: 10.1016/j.gerinurse.2022.08.004. Epub 2022 Aug 31.

GBA1 and The Immune System: A Potential Role in Parkinson's Disease?

Al-Azzawi ZAM, Arfaie S, Gan-Or Z.

J Parkinsons Dis. 2022;12(s1):S53-S64. doi: 10.3233/JPD-223423.

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

Zhao F, Cheng Z, Piao J, Cui R, Li B.

Front Pharmacol. 2022 Aug 17;13:947785. doi: 10.3389/fphar.2022.947785. eCollection 2022.

Potential therapeutics against neurological disorders: Natural products-based drugs

Rauf A, Rahman MM.

Front Pharmacol. 2022 Aug 19;13:950457. doi: 10.3389/fphar.2022.950457. eCollection 2022.

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening

Ma C, Seong H, Li X, Yu X, Xu S, Li Y.

Stem Cells Int. 2022 Aug 25;2022:2150680. doi: 10.1155/2022/2150680. eCollection 2022.

CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder

Jiang T, Wang Y, Wang X, Xu J.

Front Neurosci. 2022 Aug 18;16:988265. doi: 10.3389/fnins.2022.988265. eCollection 2022.

Recent Advancements in CNS Acting Drugs: A Step Towards End of Illness

Javed MN, Pottoo FH, Naim MJ, Chawla PA.

CNS Neurol Disord Drug Targets. 2022;21(10):882-883. doi: 10.2174/187152732110220722112205.

Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review

Verhoeff MC, Koutris M, Tambach S, Eikenboom D, de Vries R, Berendse HW, van Dijk KD, Lobbezoo F.

Eur J Pain. 2022 Nov;26(10):2036-2059. doi: 10.1002/ejp.2031. Epub 2022 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias